IL2RG binding molecules and methods of use
US12077594B2 · kind B2 · utility
0Cited by
4References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2021 |
| Grant date | Sep 3, 2024 |
| Priority date | — |
| Expiry date | Aug 29, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL2Rg, compositions comprising such antibodies, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.